Publication | Open Access
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
74
Citations
61
References
2019
Year
The XL platform represents a preclinical tool for functional gene validation and proof-of-concept studies to identify novel druggable vulnerabilities in colorectal cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1